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Abstract Obesity is a complex multifaceted disease result-
ing from interactions between genetics and lifestyle. The
proportion of phenotypic variance ascribed to genetic vari-
ance is 0.4 to 0.7 for obesity and recent years have seen
considerable success in identifying disease-susceptibility
variants. Although with the advent of genome-wide associ-
ation studies the list of genetic variants predisposing to
obesity has significantly increased the identified variants
only explain a fraction of disease heritability. Studies of
gene–environment interactions can provide more insight
into the biological mechanisms involved in obesity despite
the challenges associated with such designs. Epigenetic
changes that affect gene function without DNA sequence
modifications may be a key factor explaining interindividual
differences in obesity, with both genetic and environmental
factors influencing the epigenome. Disentangling the rela-
tive contributions of genetic, environmental and epigenetic
marks to the establishment of obesity is a major challenge
given the complex interplay between these determinants.
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Introduction
Obesity was once considered a problem of economically
developed countries, but the number of overweight and obese
people is now dramatically increasing in low- and middle-
income countries at a rate never seen before [1]. If recent
trends continue unabated, by 2030, the absolute numbers
could rise to a total of 2.16 billion overweight and 1.12 billion
obese individuals, or 38 % and 20 % of the world’s adult
population, respectively [2].
As the fundamental cause of obesity and overweight
(defined by anthropometric measures: body mass index
[BMI], waist circumference [WC] and/or waist-to-hip ratio
[WHR]) is an energy imbalance between calories consumed
on the one hand and calories expended on the other hand,
increases in rates of obesity must reflect a state of positive
energy balance, which is very likely a result of the profound
changes in society and in behavioral patterns of populations
over recent decades. Indeed, it is widely accepted that mul-
tiple factors contribute to this epidemic, including economic
growth, modernization, urbanization and, most importantly,
changes in our lifestyle, as eating habits have shifted to
greater consumption of energy-dense foods that are high in
fats and sugars, while at the same time, physical activity has
decreased [1, 3]. Although a healthy lifestyle could be the
apparent remedy for obesity, its implementation in the gen-
eral population has proven difficult so far. Given the fact
that people respond differently to the “obesogenic” environ-
ment owing to genetic predisposition, understanding the
causes and pathophysiology of obesity is very important
for prevention and therapy. Even in the presence of a strong
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“obesogenic” environment, hereditary factors remain key
contributors to the disease etiology. Ethnic/racial differences
in obesity even in comparable environments [4, 5] indicate
that obesity is most likely the result of a complex interplay
between multiple genetic, behavioral, social and environ-
mental factors that affect energy balance and, thus, body
weight regulation [6–9].
Over the past two decades, numerous strategies have been
employed for the identification of genetic determinants of
obesity, including studies of severe forms of obesity, genome-
wide linkage studies, candidate gene analyses and genome-
wide association studies (GWAS). Since 2005, the novel
GWAS approach has led to breakthrough progress in our
understanding of the genetic determinants of common obesity.
Almost 50 loci have been identified and are collectively
reported in the National Human Genome Research Institute
GWAS catalogue (http://www.genome.gov/gwastudies/) [10].
Among those GWAS findings, the first obesity susceptibility
locus identified was the FTO gene, which has the largest effect
on obesity risk to date; each additional risk allele in FTO was
shown to be associated with a 1- to 1.5-kg increase in body
weight and a 20 % to 30 % increase in obesity risk [11, 12].
Since it is widely assumed that gene–environment interaction
(GEI) must have an effect on adiposity, several epidemiologic
studies have explored the relationship between lifestyle and
obesity susceptibility genes, reporting significant interactive
effects. Despite discrepancies in the reported results, some
new insights into the role of gene–lifestyle interaction in obesity
have been obtained. In the current review, we evaluate the
recent successes in the examination of GEI in obesity and
describe the main findings. We then examine the machinery
that underlies GEI in obesity, focusing on epigenetics and
particularly DNA methylation as a mechanism for these inter-
actions. Finally, we discuss the challenges of the existing and
emerging approaches in studying GEI.
Genetic Determinants of Obesity
Until recently, progress in finding obesity-susceptibility
genes was rather slow. Numerous groups have been involved
in research related to the genetics of common obesity, with a
major focus on candidate gene studies. Those genes were
selected based on their known functional role in physiologic
pathways (e.g. regulating body weight or energy metabolism)
[13]. Between 1996 and 2005, the Obesity Gene Map (http://
obesitygene.pbrc.edu/) extensively evaluated all published
results, including monogenic forms of obesity, transgenic
and knockout animal models, quantitative trait loci from ani-
mal cross-breeding experiments, linkages from genome scans
and candidate gene association studies [14]. In the last update
of the Obesity Gene Map published in 2006, 127 candidate
genes were reported, of which less than 20 % were replicated
by 5 or more studies. Such a high level of non-replication was
the result of many limitations of the candidate gene study
approach, such as small sample size and, thus, insufficient
statistical power to detect small effects, as well as lack of type
1 error control, among others [15•].
In the past few years, a novel approach (GWAS) that
involves scanning of many thousands of samples using the
latest advances in genotyping technology (i.e. high-density,
genome-wide arrays to assay hundreds of thousands of
single nucleotide polymorphisms [SNPs] that capture the
majority of common variation in the human genome) have
led to breakthrough progress in the identification of obesity-
susceptibility genes. To date, large-scale meta-analyses of
GWAS for overall and abdominal obesity along with a
recent GWAS meta-analysis for percent body fat (%BF)
have reported 32 genetic loci associated with BMI, 14 loci
related to WHR and 2 loci for %BF (see Day and Loos [15•]
for a recent overview of GWAS findings of obesity-related
traits). The effect sizes of the 32 established BMI-associated
loci ranged from 0.06 to 0.39 kg/m2 (or ~0.17 to ~1.13 kg
for an adult of ~170 cm in height) per risk allele, with the
FTO gene having the largest effect size [16]. For the 14
novel WHR loci, the effect sizes varied from 0.019 to 0.042
units per risk allele [17], while the risk alleles for the new
%BF loci were associated with an increase ranging from
0.14 to 0.33 % in body fat [18]. Remarkably, the combined
effect of all obesity-associated variants is very modest and
explains less then 2 % of the BMI heritability [16]. Since
the heritability of BMI is estimated to be relatively high
(between 40 % and 70 % [15•]), the major question is:
what accounts for the missing heritability? Among the
suggested explanations is that the modifying effects of
environmental factors on genetic predisposition to obesity
might partially account for the unexplained interindividual
variation in BMI [19••].
Lifestyle Risk Factors for Obesity
Many specialists and scientists in the obesity research field
agree that the dramatic increase in the prevalence of over-
weight and obesity over the past few decades is mainly
attributable to the modern (Western) lifestyle, which is char-
acterized by an excessive caloric intake and a sedentary
lifestyle [1]. On the basis of many observational and epide-
miologic studies, we currently know that the major environ-
mental risk factors for obesity are unhealthy dietary habits
(e.g. low in vegetables and fruits high in fat), decreased
physical activity and alcohol consumption [20–25]. Overall
and abdominal obesity show a negative association with
such modifiable lifestyle habits as a Mediterranean-type
diet, moderate alcohol consumption and daily physical ac-
tivity [26]. However, all these well-established risk factors
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for obesity cannot explain a large proportion of the obesity
cases, as there is a high interindividual susceptibility to
weight gain in a common “obesogenic” environment. Thus,
the most accepted point of view is that the modern obesity
epidemic occurs due to a complex interplay between multi-
ple genetic, behavioral and environmental factors. Recently,
Speakman and colleagues [27•] suggested a new interesting
model for body weight regulation to explain the mechanism
underlying the current obesity epidemic. Briefly, this model
suggests the presence of upper and lower boundaries defin-
ing the set points at which physiologic regulation of body
weight and/or fatness becomes activated. While the distance
between these intervention points is genetically determined,
the changes in body weight depend on the prevailing direc-
tion of the environmental pressure (e.g. in the presence of an
“obesogenic” environment with increased food supply driv-
ing up food intake, only some people become obese). The
hypothesis provides a compelling explanation for the ob-
served complexity of the obesity problem and integrates
data and research from both the behavioral–nutritional and
the molecular genetic–physiologic fields [27•].
Studies on GEI in Obesity
It is well recognized that the investigation of GEI in obesity
etiology has not been given sufficient attention in genetic
studies [19••]. The majority of GWAS, in particular, have
not examined GEI, mainly due to lack of data on environ-
mental measurements [28]. GEI refers to the situation in
which genotypes only have their effect in the context of an
environment and environments have modifying effects that
are dependent on genotypes. In other words, in the presence
of the “obesogenic” environment, some individuals with a
genetic predisposition to develop obesity will be more prone
to gain weight compared with individuals with genetic
“resistance” to obesity [29]. A growing body of recent
evidence supports a significant role of GEI in obesity and
related metabolic diseases [30–32, 33••]. To provide an
overview on the most current publications in relationship
to GEI in obesity, we searched PubMed (February 15, 2012)
using a combination of keywords for genetic studies (i.e. gene,
genetic variant, polymorphism, SNP), different obesity-
related phenotypes (i.e. overweight, obesity, BMI, waist, hip,
WHR, fat, adiposity) and environmental factors (i.e. feeding,
diet, physical activity, alcohol, smoking, stress). This retrieved
522 papers published since January 1, 2011, of which 29 were
selected as the most relevant to the present review.
The selected papers examined 1) candidate genes for
obesity known to play a role in the functional pathways
related to metabolic regulation and 2) novel obesity-
susceptibility loci identified in recent GWAS. Two approaches
were used to investigate the relationship between those genes
and different lifestyle factors, such as dietary components,
eating habits, physical activity, sedentary behavior and psy-
chological stress: observational and intervention studies. The
observational studies are relatively easy to perform. As soon
as environmental exposures and genotyping information are
collected, the GEIs are examined using cross-sectional or
case–control designs. However, the major limitation of these
designs is their inability to identify the individual and com-
bined effects of the genetic and lifestyle risk factors or, in other
words, to answer the question of how genetic predisposition
and behavior combine to determine the risk of obesity [34].
Moreover, the observational studies are susceptible tomultiple
sources of bias (e.g. selection or recall bias) because environ-
mental exposure and the outcome of interest are assessed
simultaneously. In contrast, intervention study designs allow
minimization of bias and provide direct control of the envi-
ronmental factors by defining the experimental conditions
a priori (e.g. a specific diet or level of physical activity).
However, because these studies are usually small and short
term, they have low statistical power and are not appropriate
for investigating long-term effects [32].
GEI Studies for Candidate Genes
Overall, the investigation of GEI for biological candidate
genes has not been very successful and only a few findings
for GEI in obesity were replicated in independent studies.
This is the result of small effect sizes and very modest levels
of significance for the majority of candidate genes proven to
be associated with obesity [34]. Furthermore, as interaction
effect sizes are likely to be of even smaller magnitude, many
published small-scale reports of GEI for obesity were un-
derpowered and, thus, are probably false positive [33••].
Since January 1, 2011, a few studies have reported GEI
consistent with those from previous studies (Table 1 pro-
vides a summary of the most relevant GEI studies in obesity
published during the past year) [30–32]. For example, var-
iants in the β2-adrenergic receptor (ADRB2)- rs1042714
(Gln27Glu) and rs1042713 (Arg16Gly)- were associated
with higher risk of obesity among the individuals with
unhealthy lifestyles (i.e. smoking and reduced physically
activity) [35, 36] and were shown to have a moderating
effect on diet-induced changes on body weight and body
composition [37]. Significant genotype–dietary fat interac-
tions for obesity traits have also been reported for the
apolipoprotein genes that regulate lipid metabolism
(APOA1, APOA2, APOA5, APOB) [38–40], confirming pre-
viously observed GEI: the APOA2–saturated fat interaction
on body weight and the protective effect of the APO5-
1131 C minor allele on obesity in individuals on high-fat
diets [39–41]. In addition, an association between APOE
genotypes and increased BMI and WC dependent on psy-
chological stress was reported in Danish men [42]. Also, the
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peroxisome proliferator-activated receptor-γ (PPARγ) gene,
which has been extensively studied for GEI related to obe-
sity and type 2 diabetes [32, 43], was reported to have a diet-
related effect on risk to obesity with the Pro12 allele being
associated with increased adiposity in a high-fat diet group
[44]. In addition, the lactase (LCT) gene was shown to be
associated with risk to obesity only in individuals who had
high milk consumption [45]. Three additional observational
studies investigated multiple candidate genes from metabol-
ically relevant pathways: a few positive associations be-
tween genes, dietary components and obesity were
observed (Table 1) [46–48].
In the past year, several intervention studies reported
GEIs for variants in the leptin (LEP) [49] and the perilipin
(PLIN1) genes [50] being associated with difference in
weight loss in responses to calorie-restricted diets. In con-
trast, no evidence was found for the effect of variation in the
melanocortin-3 receptor (MC3R) gene on weight loss after a
10-week dietary intervention with hypo-energetic diets in
obese Europeans (n0760) [51].
GEI Studies for GWAS Genes
The investigation of GEI for obesity-susceptibility loci iden-
tified in recent GWAS is thought to be a more useful
strategy than the candidate gene approach. The power to
detect GEIs for GWAS loci proven to be robustly associated
with obesity is very likely to be higher because of the gene’s
strengthened causal inference for an interaction [33••].
Among the recent publications examining GEIs of GWAS
loci (Table 2), the majority of observational studies evalu-
ated whether dietary components and physical activity in-
teract with variation in the FTO gene for their effect on
obesity [52–56]. While three studies observed that the effect
of the FTO risk alleles for obesity was modulated by energy
intake or physical activity [52–54], one study with a sample
size of more than 6,000 individuals found no evidence for
this GEI [55]. The issue was clarified by an impressively
large meta-analysis that included data from 45 studies in-
volving 218,166 adults and 9 studies comprising 19,268
children and adolescents [57••]. This meta-analysis con-
firmed that the minor allele of the FTO rs9939609 variant
increases the risk of obesity in adults and showed that this
risk was reduced among physically active individuals by
27 %. This interaction was more pronounced in North
American than in European individuals. The investigators
highlighted that their finding is highly relevant for pub-
lic health implications at the population level (i.e. the
individuals with a high genetic susceptibility to obesity
can reduce their risk by living a physically healthy lifestyle)
[57••]. In addition, a novel finding of the breastfeeding pro-
tective effect on the relationship between FTO variants and
adiposity indices in Greek children from the ages of three
upward has been published [58]. A further three papers
reported the effect of lifestyle modifications on the
relationship between several GWAS genes and obesity-
related traits in observational [59] and intervention studies
(Table 2) [60, 61].
Among the recently published papers, two clinical trials
reported GEI in response to weight loss interventions. Qi
and colleagues [62•] found a novel association between the
variant in the insulin receptor substrate 1 (IRS1) gene and
response to a weight loss diet: 738 overweight adults (61 %
were women) were randomly assigned to 1 of 4 diets vary-
ing in macronutrient contents for 2 years. Participants with
the IRS1 rs2943641 CC genotype had greater weight loss
and improvement of insulin resistance than those without
this genotype in response to a high-carbohydrate/low-fat
diet. Interestingly, the variant rs2943650 (r201.00 with
rs2943641) near IRS1 has been reported in a recent GWAS
for percentage body fat with the fat percentage–decreasing
allele being associated with (counterintuitively) higher lev-
els of insulin resistance [18]. Another study, a randomized
controlled trial in overweight and obese adults (n03,234),
investigated the effect of 16 novel GWAS obesity-
susceptibility variants on weight loss during a 2-year inter-
vention program. The researchers reported gene–lifestyle
interactions for short-term and long-term weight loss [63•].
Altogether, these novel findings provide supportive infor-
mation for the development of effective dietary intervention
strategies based on genetic background.
So far, only one study has examined whether the genetic
predisposition to obesity risk assessed by a genetic risk
score (GRS) was modified by lifestyle factors. A large-
scale population-based study (n020,430) investigated the
effect of a GRS calculated by summing 12 BMI-increasing
alleles across the 12 genetic variants and its interaction
with physical activity on obesity risk. The researchers
found that the genetic risk of obesity was attenuated by
40 % in physically active individuals compared with
physically inactive individuals [64••]. These results pro-
vide further evidence that particular individuals who are
genetically predisposed to obesity would benefit more
from elevated physical activity levels than individuals
who are genetically protected. Importantly, these find-
ings also indicate that GEIs might contribute to the
unexplained variance in obesity traits and suggest that
future GWAS of obesity-related traits studying, for ex-
ample, physically inactive individuals may discover new
obesity-susceptibility loci because the effect sizes of
genetic variants may be more pronounced and, thus,
more easily identified. To our knowledge, numerous
consortia-based meta-analyses are ongoing in which this
innovative genome–environment-wide association ap-
proach is deployed, but so far, no results of these
studies have been published.
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Machinery That Underlies GEI
Environment has inarguably a large impact on human phys-
iologic functions and health. Despite the recent successes in
identifying genetic determinants accounting for obesity, the
definition and quantification of GEIs has proven difficult.
Environmental exposure to nutritional and other stimuli can
alter the expression of a subset of genes through changes in
the epigenome [65]. Although little is known about the
exact role of the epigenome in the pathophysiology of
obesity, epigenetic regulation of gene expression may be a
key factor explaining interindividual differences in
adiposity-related phenotypes [66] and the study of the epi-
genome offers hope in understanding the machinery that
underlies complex GEIs.
Epigenetics
Epigenetics is loosely defined as the study of heritable
changes in gene function without modifications in DNA
sequences [67]. Epigenetic changes include DNA methyla-
tion, chromatin folding and binding, packaging of DNA
around nucleosomes and covalent modifications of the his-
tone proteins that make up the nucleosomes around which
the DNA double helix is coiled [68]. The epigenome varies
across different cell types and undergoes precise, coordinated
changes during a lifetime [69••, 70].
DNA methylation is a well-studied epigenetic modifica-
tion that involves the addition of a methyl (CH3) group to a
cytosine located next to a guanine nucleotide (CpG) in CpG
dinucleotide–rich regions [70]. Methylation in promoters-
associated CpG islands is associated with a transcriptionally
repressed state established by two main mechanisms: inability
of transcriptional factors to bind to their cognate sequence due
to the presence of a methyl group within the binding site
or the attraction of methyl-CpG-binding proteins with
repressive properties [71, 72].
Environmental and Genetic Effects on the Epigenome
in the Context of Obesity
There is increasing evidence of epigenetic regulation of
metabolic diseases further supporting a link between genes
and environment through their influences on the epigenome
[73]. Periconceptional and gestational periods are particu-
larly sensitive to epigenetic perturbation, with the environ-
ment exerting different effects on the placenta and embryo
[69••]. In particular, nutrition at different developmental
stages can influence the epigenome, potentially contributing
to an increased susceptibility to chronic diseases, such as
obesity [65, 66]. In mammals, early nutrition and in
particular dietary components, such as folate, vitamin B6,
vitamin B12, betaine, methionine and choline have been
associated with changes in DNA methylation patterns by
affecting the one-carbon metabolism that ultimately pro-
vides the methyl groups for DNA and histone methylation
[69••]. Furthermore, maternal food supplementation with
bisphenol A—a DNA hypomethylated compound that can
leach from polycarbonate plastics into their contents—has
been associated with decreased methylation at the Avy allele
(the viable yellow agouti allele is a murine metastable
epiallele that is variably expressed due to epigenetic marks
established during early development) in the offspring and
with obesity in early and later life in mammals [68, 74],
whereas supplementation of maternal diet with folic acid or
genistein negated the hypomethylating effects of BPA [68].
Maternal exposure to several other chemicals (the so-called
obesogens) has been associated with increased BMI in off-
spring, further suggesting that obesity is being programmed
prenatally or in early childhood and disruption of normal
epigenetic regulation that alters the expression of key genes
in adipogenic pathways is likely to be involved [75]. Nev-
ertheless, our understanding of how environmental influ-
ence on epigenetic marks can lead to obesity remains
rather rudimentary. The potential interaction of environment
with the epigenome mediating the expression of genes as-
sociated with increased adiposity has also been suggested
[76]. For example, the FTO gene encodes for an enzyme that
is able to remove methyl groups from DNA [77], long-term
exposure to high-fat diet can decrease the melanocortin-4
receptor (MC4R) gene methylation [78] and high-fat diet–
induced obesity can modify leptin methylation patterns [79].
The expression of the PPARγ gene, a key regulator of adipo-
cyte differentiation, was found to be reduced due to DNA
methylation of its promoter in adipocytes of visceral adipose
tissue in mammals [80]. Several other genes involved in
adiposity have promoters that seem to be epigenetic targets
in relation to obesity (epi-obesogenic genes) [66]. One of the
first genome-wide methylation studies revealed increased
methylation levels at one CpG site (UBASH3A gene) and
decreased methylation levels at one CpG site (TRIM3 gene)
in obese subjects compared with lean controls, providing
evidence that obesity is associated with epigenetic changes
[81•]. Although collectively, these studies could indicate that
epigenetic marks lead to obesity, it is not really clear whether
they predict or precede obesity [82••]. The causal relationship
between epigenetic marks and obesity has yet to be elucidated
and other factors, such as nutrition or physical activity, that
correlate with both DNA methylation and increased adiposity
should be considered to this end [82••]. Genetic differences
between individuals can also influence epigenetic regulation
[69••] and genetic variants could account for the locus-specific
variance in epigenetic states. In humans, it has been shown
that 10 % of common SNPs are located in regions with
Curr Nutr Rep (2012) 1:184–196 191
differences in the propensity for local DNA methylation be-
tween the two alleles [83]. With this in mind, it is possible that
the interplay of genetics and epigenetics could underlie the
establishment of diseases, such as obesity. However, the ex-
tent to which DNA sequence determines epigenetic changes at
specific loci and subsequently leads to obesity is poorly un-
derstood. Evaluating the relative contribution of genetic and
environmental factors to the establishment of the epigenome
and elucidating the causal relationship between epigenetics
and obesity constitute major challenges given the complex
interrelationship of those determinants (Fig. 1).
Transgenerational Epigenetic Inheritance
Currently, there is increased evidence that environmentally
induced epigenetic changes can also be passed to the next
generation via gametes and not only through the placenta in
the developing embryo (maternal diet) or through breast-
feeding in the infant [84]. Transgenerational epigenetic in-
heritance is also supported by the fact that some epigenetic
marks escape reprogramming—that is, erasure and resetting
of the gametic epigenome between generations [73]. This
reprogramming escape, in combination with the observation
that parental exposure to challenging environments, results
in maladaptive responses that can be passed to the next
generation renders trasngenerational epigenetic inheritance
a mechanism of great interest, especially for obesity. A
recent study in mice has examined the effect of a maternal
exposure to a high-fat diet on body size, not only in the
second generation (F2), but also in the third one (F3) in
order to test whether the phenotype is transmitted by a
germline-based epigenetic mark. Interestingly, the study
has shown that the increased body size and length pheno-
types were transmitted to F3 females through the F2 paternal
lineage, suggesting that maternal high-fat diet programs a
germline-based transgenerational phenotype in male game-
tes [85]. With this in mind, it is possible that environmen-
tally induced epigenetic changes could in theory explain a
significant fraction of the missing heritability for adiposity-
related phenotypes by affecting both disease penetrance
and heritability [86].
Challenges of GEI Studies
GEI studies can be very helpful in unraveling the biological
pathways important for predicting disease risk and possibly
in explaining some of the missing heritability through the
identification of obesity-susceptibility genes that exert their
effects through interaction with environment. Furthermore,
GEIs could potentially be used for the identification of
Fig. 1 A model of the interplay
between environmental/genetic
factors and epigenetic changes
in the establishment of obesity.
Genes, environment, and
epigenetic marks can directly
lead to increased adiposity.
Genes and environment can
interact through their influence
on the epigenome. Although
epigenetic changes may cause
obesity, it is often not really
clear if they precede obesity,
or vice versa
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environmental factors that affect individuals with specific
genotypes [19••]. However, the investigation of such inter-
actions in complex diseases such as obesity remains a chal-
lenging task, with the major limitations including sample
size/power, measurement of environmental factors, hetero-
geneity and lack of replication. Typically, thousands of
samples are needed in candidate gene–based studies or even
more in GWAS, in which very stringent cutoffs of signifi-
cance are used. Not all reviewed studies have had a suffi-
cient sample size to detect interactions and the lack of
control for type 1 error continues to be a concern. In addi-
tion to that, accurate measurement of exposures that vary
over time or are modifiable by other factors, such as time of
exposure, has proven difficult and can create biases in the
analysis. Another important issue is the observed heteroge-
neity in the study design that arises due to differences in the
way that examined environmental exposures are assessed
across studies and due to the possible study-specific char-
acteristics of exposure [19••]. Recent efforts in the estab-
lishment of prospective cohorts (e.g. the National Children’s
Study [http://www.nationalchildrensstudy.gov] and the
Avon Longitudinal Study of Parents and Children [http://
www.bristol.ac.uk/alspac/]) with robust and repeated meas-
urements over time of environmental exposures can help in
assessing the role of critical windows of susceptibility that
likely correspond to the expression of specific genes. The
challenges related to GEI studies were the topic of discussion
in a recent workshop at which more than 150 researchers
representing a wide range of scientific areas participated.
Interesting questions were raised and useful recommendations
were given regarding GEI study design for overcoming the
aforementioned limitations. The need for integration of envi-
ronment, genetics and epigenetics in the same study was also
emphasized, as this could provide insight into their complex
interactive role in the establishment of disease [87••]. In the
post-GWAS era, the careful design of epidemiologic studies,
accurate measurement of exposures and use of standardized
methods across studies should facilitate collaborations, which
will increase statistical power for assessing GEIs. With the
completion of the Human Epigenome Project (http://www.
epigenome.org/) [88], a more comprehensive picture of the
genetic factors and epigenetic marks underlying cellular ho-
meostasis will be achieved. Determination of disease-specific
epigenetic changes and integration of this information with
genetic and known environmental risks to obesity will provide
more insights and will be proven valuable in predicting the
onset and progress of obesity.
Conclusions
Obesity is a complex disease with multiple environmental and
genetic causes. Over recent years, the GWAS experimental
design has led to the identification of a number of obesity-
susceptibility genes that, however, only explain a small por-
tion of the interindividual variation in adiposity. Identifying
the genes that predispose to obesity in combination with
specific environmental exposures is very important for better
understanding of disease etiology and subsequently for dis-
ease treatment and prevention. The investigation of gene–
environment interplay can also unravel the pathways involved
in obesity and be beneficial for drug development and therapy.
To date, studies of GEIs have been facing challenges and,
thus, are limited compared with those examining only
main genetic or environmental effects. Furthermore, the
contribution of the epigenome to the establishment of
obesity is largely unknown. Further GEI studies that are
carefully designed can extend the list of genetic loci
that exert effects in the presence of specific environ-
mental exposures. The next generation of studies incor-
porating genetic–environment–epigenome information
and utilizing new analytical approaches and environmen-
tal measurement technologies can improve understanding of
the complex causes of obesity.
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